Abstract
We conducted a comparative survey of incidence and prevalence of pulmonary sarcoidosis in Southern (Crimean AR) and Northern (Zhytomyr region) regions of Ukraine by means of analysis of self-referred cases and cases, revealed at prophylactic radiological examination in 2011. The incidence of sarcoidosis in Crimea was 1.08 per 100 000 adult inhabitants; the prevalence was 4,59 per 100 000. In Zhytomyr region the incidence value (2,62 per 100 000) exceeded an equivalent value in Crimea by 2,4 times. The prevalence (7,86 per 100 000) was also higher than in Crimea by 1,7 times. Taking into account a significant impact of climate factor on sarcoidosis epidemiology, the incidence and prevalence of disease in Northern and Southern regions should be considered polar as for the regions of Ukraine. This makes it possoble to conclude that mean incidence of sarcoidosis in Ukraine ranges from 1,1 to 2,6 per 100 000 adult population, whereas the prevalence – from 4,6 to 7,9 per 100 000, which is equivalent to the level of Southern European countries.
Highlights
Incidence of respiratory tract sarcoidosis in southern and northern regions of Ukraine
Ɂɚɝɚɥɶɧɚ ɤɿɥɶɤɿɫɬɶ ɯɜɨɪɢɯ ɡ ɚɤɬɢɜɧɢɦ ɫɚɪɤɨʀɞɨɡɨɦ ɭ 2011 ɪɨɰɿ – 89 (53 ɠɿɧɤɢ ɬɚ 36 ɱɨɥɨɜɿɤɿɜ, ɫɟɪɟɞɧɿɣ ɜɿɤ – 50,6 ɪɨɤɭ). ɉɨɤɚɡɧɢɤ ɩɨɲɢɪɟɧɨɫɬɿ – 4,59 ɧɚ 100 000. ȱ ɫɬɚɞɿɹ ɫɚɪɤɨʀɞɨɡɭ ɫɩɨɫɬɟɪɿɝɚɥɚɫɶ ɭ 14 ɯɜɨɪɢɯ (15,7%), ȱȱ ɫɬɚɞɿɹ – ɭ 46 (51,6%), ȱȱȱ ɫɬɚɞɿɹ – ɭ 17 (19%), ȱV ɫɬɚɞɿɹ – 12 (13%)
Ɂɧɚɱɧɿ ɜɿɞɦɿɧɧɨɫɬɿ ɪɿɜɧɿɜ ɡɚɯɜɨɪɸɜɚɧɨɫɬɿ ɬɚ ɩɨɲɢɪɟɧɨɫɬɿ ɫɚɪɤɨʀɞɨɡɭ ɜ ɩɿɜɧɿɱɧɢɯ ɬɚ ɩɿɜɞɟɧɧɢɯ ɪɟɝɿɨɧɚɯ ɨɞɧɿɽʀ ɤɪɚʀɧɢ ɜɿɞɡɧɚɱɟɧɿ ɜ ȱɪɥɚɧɞɿʀ ɬɚ Ⱦɚɧɿʀ – ɤɪɚʀɧɚɯ, ɳɨ ɡɧɚɱɧɨ ɩɨɫɬɭɩɚɸɬɶɫɹ ɍɤɪɚʀɧɿ ɡɚ ɪɨɡɦɿɪɚɦɢ
Summary
Incidence of respiratory tract sarcoidosis in southern and northern regions of Ukraine. Ɂɚɯɜɨɪɸɜɚɧɿɫɬɶ ɧɚ ɫɚɪɤɨʀɞɨɡ ɭ ɪɿɡɧɢɯ ɤɪɚʀɧɚɯ ɫɜɿɬɭ ɜɚɪɿɸɽ ɜɿɞ 0,125 ɞɨ 24,0 ɧɨɜɢɯ ɜɢɩɚɞɤɿɜ ɧɚ 100 000 ɧɚɫɟɥɟɧɧɹ ɧɚ ɪɿɤ, ɩɨɲɢɪɟɧɿɫɬɶ – ɜɿɞ 1 ɞɨ 64 ɧɚ 100 000 ɧɚɫɟɥɟɧɧɹ [2]. Ɇɟɬɚ ɞɨɫɥɿɞɠɟɧɧɹ – ɩɪɨɜɟɫɬɢ ɩɨɪɿɜɧɹɥɶɧɟ ɜɢɜɱɟɧɧɹ ɡɚɯɜɨɪɸɜɚɧɨɫɬɿ ɧɚ ɫɚɪɤɨʀɞɨɡ ɨɪɝɚɧɿɜ ɞɢɯɚɧɧɹ ɜ ɩɿɜɞɟɧɧɨɦɭ ɬɚ ɩɿɜɧɿɱɧɨɦɭ ɪɟɝɿɨɧɚɯ ɍɤɪɚʀɧɢ.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
